N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model

Journal of Clinical Immunology

Volumn 33, Issue 3, 2013, Pages 649-660

  Wang, Hong Wei ^a   Yang, Wen ^a   Lu, Jiang Yang ^a   Li, Fei ^a   Sun, Jun Zhong ^a   Zhang, Wen ^a   Guo, Nan Nan ^a   Gao, Lei ^a   Kang, Jia Rui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Dendritic cells; Generalized inflammation; N acetylcysteine; Nuclear factor kappa B

Indexed keywords

ACETYLCYSTEINE; B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; HLA A ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTERIAL GAS; ARTICLE; CCR5 GENE; CCR7 GENE; CELL FUNCTION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; HISTOPATHOLOGY; INFLAMMATION; LUNG; LUNG FUNCTION; LUNG INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION; LUNG; MALE; MICE; NF-KAPPA B; RECEPTORS, CCR5; RECEPTORS, CCR7; RESPIRATORY FUNCTION TESTS; RNA, MESSENGER; ZYMOSAN;

EID: 84879882220     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9852-3     Document Type: Article

References (32)

1. Barie PS, Hydo LJ, Shou J, Eachempati SR. Decreasing magnitude of multiple organ dysfunction syndrome despite increasingly severe critical surgical illness: a 17-year longitudinal study. J Trauma. 2008;65:1227-35.
2. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996;125:680-7.
3. Perl M, Chung CS, Garber M, Huang X, Ayala A. Contribution of anti-inflammatory/immune suppressive processes to the pathology of sepsis. Front Biosci. 2006;11:272-99.
4. Joffre O, Nolte MA, Spirri R, Reise Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev. 2009;227:234-47.
5. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106:259-62.
6. Efron PA, Martins A, Minnich D, Tinsley K, Ungaro R, Bahjat FR, Hotchkiss R, Clare-Salzler M, Moldawer LL. Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J Immunol. 2004;173:3035-43.
7. Scumpia PO, McAuliffe PF, O'Malley KA, Ungaro R, Uchida T, Matsumoto T, Remick DG, Clare-Salzler MJ, Moldawer LL, Efron PA. CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J Immunol. 2005;175:3282-6.
8. Benjamim CF, Lundy SK, Lukacs NW, Hogaboam CM, Kunkel SL. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood. 2005;105:3588-95.
9. Tinsley KW, Grayson MH, Swanson PE, Drewry AM, Chang KC, Karl IE, Hotchkiss RS. Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J Immunol. 2003;171:909-14.
10. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol. 2006;6:813-22.
11. Hardaway RM. A brief overview of acute respiratory distress syndrome. World J Surg. 2006;30:1829-34.
12. Wesche DE, Loma-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte apoptosis and its significance in sepsis and shock for the treatment of sepsis. J Leukoc Biol. 2005;78:325-37.
13. Kelly GS. Clinical applications of N-acetylcysteine. Alternative Med Rev. 1998;3:114-27.
14. Ozdulger A, Cinel I, Koskel O, Cinel L, Avlan D, Unlu A, Okcu H, Dikmengil M, Oral U. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock. 2003;19:366-72.
15. Paterson RL, Galley HF, Webster NR. The effect of Nacetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003;31:2574-8.
16. Suter PM, Domenighetti G, Schaller MD, Laverrière MC, Ritz R, Perret C. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest. 1994;105:190-4.
17. Liu DD, Kao SJ, Chen HI. N-acetylcysteine attenuates acute lung injury induced by fat embolism. Crit Care Med. 2008;36:565-71.
18. Verhasselt V, Vanden Bergh W, Vanderheyde N, Willems F, Haegeman G, Goldman M. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kB inhibition. J Immunol. 1999;162:2569-74.
19. Wolman TJ, Hendriks T, Goris RJ. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock. 2005;23:291-7.
20. Goris RJ, Boekholtz WK, van Bebber IP, Nuytinck JK, Schillings PH. Multiple organ failure and sepsis without bacteria: an experimental model. Arch Surg. 1986;121:897-901.
21. Cuzzocrea S, Genovese T, Mazzon E, Esposito E, Crisafulli C, Di Paola R, Bramanti P, Salvemini D. Fumonisin B1 reduces the development of multiple organ failure induced by zymosan in mice. Shock. 2009;31:170-7.
22. Genovese T, DiPaolo R, Catalano P. Treatment with a novel poly (ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice. Crit Care Med. 2004;32:1365-74.
23. Masten BJ, Gwyneth K, Kusewitt DF, Lipscomb MF. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice. J Immunol. 2004;172:4077- 83.
24. Menezes SL, Bozza PT, Castro Fario Neto HC. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol. 2005;98:1777-83.
25. Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med. 2004;32:342-9.
26. Spapen HD, Diltoer MW, Nguyen DN, Hendrickx I, Huyghens LP. Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis. Chest. 2005;127:1413-9.
27. Xin J, Lin W, Wu HS, Zhang L, Wang CY, Tian Y, Zhang JH. N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice. Hepatob Pancreat Dis Int. 2007;6:284-9.
28. Kroening PR, Barnes TW, Pease L, Limper A, Kita H, Vassallo R. Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. J Immunol. 2008;181:1536-47.
29. Wen HT, Hogaboam CM, Gauldie J, Kunkel SL. Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile. Am J Pathol. 2006;168:1940-50.
30. Caux C, Ait-Yahia S, Chemin K. Dendritic cell biology and regulation dendritic cell trafficking by chemokines. Springer Semin Immunopathol. 2000;22:345-69.
31. Kriehuber E, Bauer W, Charbonnier AS, Winter D, Amatschek S, Tamandl D, Schweifer N, Stingl G, Maurer D. Balance between NF-kappaB and JNK/AP-1 activity controls dendritic cell life and death. Blood. 2005;106:175-83.
32. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity. 2002;16:257-70.